BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

American Medical Systems Holdings Inc. Reports Third Quarter Results and Strong Earnings Growth


11/5/2008 11:10:13 AM

MINNEAPOLIS--(BUSINESS WIRE)--American Medical Systems Holdings, Inc. (NASDAQ: AMMD) reported revenue of $117.5 million for the third quarter of 2008, a 7.7 percent increase over sales of $109.0 million in the comparable quarter of 2007. Currency translation had a positive impact on revenue of $2.1 million in the third quarter compared to the same period last year. Third quarter 2008 adjusted net income of $10.3 million, or $0.14 per share, excludes the impact of an in-process research and development (IPRD) charge and represents a 49.3 percent and 55.6 percent increase over third quarter 2007 net income of $6.9 million, or $0.09 per share, respectively. Third quarter 2008 reported net income of $5.7 million, or $0.08 per share, includes a $7.5 million IPRD charge related to a milestone payment on the 2006 acquisition of BioControl. The Company also reported a strong cash EPS performance in the third quarter of 2008 of $0.20 per share compared to $0.17 per share in the comparable period last year, a 17.6 percent growth, reflecting solid expense and working capital management. A reconciliation of net income from continuing operations, the GAAP measure most directly comparable to cash earnings per share, to non-GAAP cash earnings per share, is provided on the attached schedule.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES